
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Sotagliflozin attenuates cardiac dysfunction and remodeling in myocardial infarction rats
Peng Zhong, Jingjing Zhang, Yanzhao Wei, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e22423-e22423
Open Access | Times Cited: 6
Peng Zhong, Jingjing Zhang, Yanzhao Wei, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e22423-e22423
Open Access | Times Cited: 6
Showing 6 citing articles:
Effect of sotagliflozin on major adverse cardiovascular events: a prespecified secondary analysis of the SCORED randomised trial
Rahul Aggarwal, Deepak L. Bhatt, Michael Szarek, et al.
The Lancet Diabetes & Endocrinology (2025)
Closed Access | Times Cited: 3
Rahul Aggarwal, Deepak L. Bhatt, Michael Szarek, et al.
The Lancet Diabetes & Endocrinology (2025)
Closed Access | Times Cited: 3
The Role of SGLT1 in Atrial Fibrillation and Its Relationship with Endothelial-Mesenchymal Transition
Zhi-Hong Ning, Xianding Wang, Huifang Tang, et al.
Biochemical and Biophysical Research Communications (2025) Vol. 748, pp. 151338-151338
Closed Access
Zhi-Hong Ning, Xianding Wang, Huifang Tang, et al.
Biochemical and Biophysical Research Communications (2025) Vol. 748, pp. 151338-151338
Closed Access
Sotagliflozin attenuates cardiac dysfunction and depression-like behaviors in mice with myocardial infarction through the gut-heart-brain axis
Lei Liao, Lu Zhang, Chengying Yang, et al.
Neurobiology of Disease (2024) Vol. 199, pp. 106598-106598
Open Access | Times Cited: 3
Lei Liao, Lu Zhang, Chengying Yang, et al.
Neurobiology of Disease (2024) Vol. 199, pp. 106598-106598
Open Access | Times Cited: 3
The Off-Target Cardioprotective Mechanisms of Sodium–Glucose Cotransporter 2 Inhibitors: An Overview
Loredana N. Ionică, Adina V. Lința, Alina D. Bătrîn, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7711-7711
Open Access | Times Cited: 2
Loredana N. Ionică, Adina V. Lința, Alina D. Bătrîn, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7711-7711
Open Access | Times Cited: 2
Extrarenal Benefits of SGLT2 Inhibitors in the Treatment of Cardiomyopathies
Veera Ganesh Yerra, Kim A. Connelly
Physiology (2024) Vol. 39, Iss. 6, pp. 412-434
Closed Access | Times Cited: 1
Veera Ganesh Yerra, Kim A. Connelly
Physiology (2024) Vol. 39, Iss. 6, pp. 412-434
Closed Access | Times Cited: 1
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors: Guardians against Mitochondrial Dysfunction and Endoplasmic Reticulum Stress in Heart Diseases
Linh Thi Truc Pham, Supachoke Mangmool, Warisara Parichatikanond
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 11, pp. 3279-3298
Open Access
Linh Thi Truc Pham, Supachoke Mangmool, Warisara Parichatikanond
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 11, pp. 3279-3298
Open Access